In the last 12 months, insiders at Alto Neuroscience, Inc. ($ANRO) filed 107 transactions with the SEC: 9 open-market purchases totaling $10,238,469 and 0 sales totaling $0. Net insider sentiment: net buying.
Alto Neuroscience, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Alpha Wave Global, LP (TenPercentOwner) — 5 transactions totaling $9,600,000
- Savitz Adam (CHIEF MEDICAL OFFICER) — 19 transactions totaling $462,833
- Etkin Amit (PRESIDENT AND CEO) — 16 transactions totaling $172,610
- Smith Nicholas Conrad (CHIEF FINANCIAL OFFICER) — 5 transactions totaling $125,636
- Smith Nicholas Conrad (CHIEF FINANCIAL OFFICER & CBO) — 13 transactions totaling $55,250
View all SEC Filings for Alto Neuroscience, Inc. (ANRO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | F | Common Stock | 2806 | $19.69 | 24,060.0000 | 31,066,335 | 10.44% | 0.01% |
| March 1, 2026 | Etkin Amit | PRESIDENT AND CEO | F | Common Stock | 6227 | $19.69 | 1,233,949.0000 | 31,066,335 | 0.50% | 0.02% |
| Feb. 11, 2026 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 306000 | $0.00 | 306,000.0000 | 31,066,335 | 9999.99% | 0.98% |
| Feb. 11, 2026 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A | Employee Stock Option (Right to Buy) | 131000 | $0.00 | 131,000.0000 | 31,066,335 | 9999.99% | 0.42% |
| Feb. 11, 2026 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 124000 | $0.00 | 124,000.0000 | 31,066,335 | 9999.99% | 0.40% |
| Feb. 11, 2026 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 31,066,335 | 9999.99% | 0.64% |
| Jan. 2, 2026 | Cox Christopher Nixon | Director | A | Stock Option (right to buy) | 7189 | $11.82 | 7,189.0000 | 31,066,335 | 9999.99% | 0.02% |
| Jan. 2, 2026 | York Gwill | Director | A | Stock Option (right to buy) | 5243 | $11.82 | 5,243.0000 | 31,066,335 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Manji Husseini | Director | A | Employee Stock Option (right to buy) | 4228 | $11.82 | 4,228.0000 | 31,066,335 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Sanchez Ramiro | Director | A | Stock Option (right to buy) | 3806 | $11.82 | 3,806.0000 | 31,066,335 | 9999.99% | 0.01% |
| Aug. 12, 2025 | Sanchez Ramiro | Director | A | Stock Option (right to buy) | 3928 | $2.21 | 3,928.0000 | 27,072,129 | 9999.99% | 0.01% |
| Aug. 12, 2025 | Sanchez Ramiro | Director | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 27,072,129 | 9999.99% | 0.11% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 123645 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.46% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 73000 | $0.00 | 73,000.0000 | 27,072,129 | 9999.99% | 0.27% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 73000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.27% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 27,072,129 | 9999.99% | 0.28% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 76000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.28% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 34620 | $0.00 | 34,620.0000 | 27,072,129 | 9999.99% | 0.13% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 34620 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.13% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 247290 | $0.00 | 247,290.0000 | 27,072,129 | 9999.99% | 0.91% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 247290 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.91% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 223000 | $0.00 | 223,000.0000 | 27,072,129 | 9999.99% | 0.82% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 223000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.82% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | D | Employee Stock Option (Right to Buy) | 215000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.79% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 44962 | $0.00 | 44,962.0000 | 27,072,129 | 9999.99% | 0.17% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 44962 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.17% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 33833 | $0.00 | 33,833.0000 | 27,072,129 | 9999.99% | 0.12% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 33833 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.12% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 202329 | $0.00 | 202,329.0000 | 27,072,129 | 9999.99% | 0.75% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 202329 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.75% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 27,072,129 | 9999.99% | 0.33% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 90000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.33% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 27,072,129 | 9999.99% | 0.50% |
| July 3, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | D | Employee Stock Option (Right to Buy) | 135000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.50% |
| July 3, 2025 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 27,072,129 | 9999.99% | 0.79% |
| July 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A | Employee Stock Option (Right to Buy) | 8000 | $0.00 | 8,000.0000 | 27,072,129 | 9999.99% | 0.03% |
| July 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | D | Employee Stock Option (Right to Buy) | 8000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.03% |
| July 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A | Employee Stock Option (Right to Buy) | 188000 | $0.00 | 188,000.0000 | 27,072,129 | 9999.99% | 0.69% |
| July 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | D | Employee Stock Option (Right to Buy) | 188000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.69% |
| July 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 27,072,129 | 9999.99% | 0.46% |
| July 3, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | D | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.46% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 22481 | $0.00 | 22,481.0000 | 27,072,129 | 9999.99% | 0.08% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 22481 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.08% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 33008 | $0.00 | 33,008.0000 | 27,072,129 | 9999.99% | 0.12% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 33008 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.12% |
| July 3, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 123645 | $0.00 | 123,645.0000 | 27,072,129 | 9999.99% | 0.46% |
| May 13, 2025 | Manji Husseini | Director | A | Stock Option (right to buy) | 15287 | $0.00 | 15,287.0000 | 27,072,129 | 9999.99% | 0.06% |
| May 13, 2025 | Dreyfus Andrew | Director | A | Stock Option (right to buy) | 15287 | $0.00 | 15,287.0000 | 27,072,129 | 9999.99% | 0.06% |
| May 13, 2025 | York Gwill | Director | A | Stock Option (right to buy) | 15287 | $0.00 | 15,287.0000 | 27,072,129 | 9999.99% | 0.06% |
| May 13, 2025 | Cox Christopher Nixon | Director | A | Stock Option (right to buy) | 15287 | $0.00 | 15,287.0000 | 27,072,129 | 9999.99% | 0.06% |
| Feb. 5, 2025 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER & CBO | A | Employee Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Hanley Jr. Michael Conick | CHIEF OPERATING OFFICER | A | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | York Gwill | Director | A | Stock Option (right to buy) | 19558 | $3.17 | 19,558.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Manji Husseini | Director | A | Stock Option (right to buy) | 14195 | $3.17 | 14,195.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Cox Christopher Nixon | Director | A | Stock Option (right to buy) | 25236 | $3.17 | 25,236.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 2931 | $13.22 | 39,851.0000 | 0 | 7.94% | 0.00% |
| July 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 1388 | $13.15 | 36,920.0000 | 0 | 3.91% | 0.00% |
| July 9, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 10681 | $12.53 | 35,532.0000 | 0 | 42.98% | 0.00% |
| May 20, 2024 | Hanley Jr. Michael Conick | Chief Operating Officer | A | Employee Stock Option (right to buy) | 188000 | $0.00 | 188,000.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P | Common Stock | 4550 | $16.56 | 26,866.0000 | 0 | 20.39% | 0.00% |
| March 28, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P | Common Stock | 1600 | $15.80 | 22,316.0000 | 0 | 7.72% | 0.00% |
| March 8, 2024 | Radhakrishnan Maha | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| March 8, 2024 | Radhakrishnan Maha | Not found | A | Stock Option (right to buy) | 1590 | $10.21 | 1,590.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Apeiron Investment Group Ltd. | Not found | C | Series B Preferred Stock | 416665 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Apeiron Investment Group Ltd. | Not found | C | Common Stock | 251881 | $0.00 | 926,539.0000 | 0 | 37.33% | 0.00% |
| Feb. 6, 2024 | Apeiron Investment Group Ltd. | Not found | C | Common Stock | 674658 | $0.00 | 926,539.0000 | 0 | 267.85% | 0.00% |
| Feb. 6, 2024 | Apeiron Investment Group Ltd. | Not found | C | Warrants to Purchase Series A Preferred Stock | 444561 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Apeiron Investment Group Ltd. | Not found | C | Series A Preferred Stock | 406072 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Apeiron Investment Group Ltd. | Not found | C | Series A Preferred Stock | 1063918 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 1, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 73000 | $0.00 | 73,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | A | Common Stock | 19153 | $0.00 | 20,716.0000 | 0 | 1225.40% | 0.00% |
| March 1, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | A | Employee Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Etkin Amit | PRESIDENT AND CEO | A | Common Stock | 34711 | $0.00 | 1,240,176.0000 | 0 | 2.88% | 0.00% |
| March 1, 2024 | Etkin Amit | PRESIDENT AND CEO | A | Employee Stock Option (Right to Buy) | 223000 | $0.00 | 223,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Alpha Wave Global, LP | TenPercentOwner | C | Series C Convertible Preferred Stock (Series C Preferred) | 1144763 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Alpha Wave Global, LP | TenPercentOwner | C | Common Stock | 1962995 | $0.00 | 1,962,995.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Alpha Wave Global, LP | TenPercentOwner | C | Common Stock | 1144762 | $0.00 | 3,107,757.0000 | 0 | 58.32% | 0.00% |
| Feb. 6, 2024 | Alpha Wave Global, LP | TenPercentOwner | P | Common Stock | 600000 | $16.00 | 3,707,757.0000 | 0 | 19.31% | 0.00% |
| Feb. 6, 2024 | Alpha Wave Global, LP | TenPercentOwner | C | Series B Convertible Preferred Stock (Series B Preferred) | 1962995 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Etkin Amit | PRESIDENT AND CEO | C | Common Stock | 11777 | $0.00 | 1,202,340.0000 | 0 | 0.99% | 0.00% |
| Feb. 6, 2024 | Etkin Amit | PRESIDENT AND CEO | P | Common Stock | 3125 | $16.00 | 1,205,465.0000 | 0 | 0.26% | 0.00% |
| Feb. 6, 2024 | Etkin Amit | PRESIDENT AND CEO | C | Series B Preferred Stock | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Chen Po Yu (Jeff) | Not found | C | Common Stock | 39259 | $0.00 | 39,259.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Chen Po Yu (Jeff) | Not found | C | Common Stock | 8450 | $0.00 | 47,709.0000 | 0 | 21.52% | 0.00% |
| Feb. 6, 2024 | Chen Po Yu (Jeff) | Not found | C | Series B Preferred Stock | 83333 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Chen Po Yu (Jeff) | Not found | C | Series C Preferred Stock | 18794 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 17000 | $16.00 | 24,851.0000 | 0 | 216.53% | 0.00% |
| Feb. 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | C | Common Stock | 7851 | $0.00 | 7,851.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Cox Christopher Nixon | Not found | C | Series C Preferred Stock | 281917 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Cox Christopher Nixon | Not found | C | Series B Preferred Stock | 1250000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | Cox Christopher Nixon | Not found | C | Common Stock | 126755 | $0.00 | 715,653.0000 | 0 | 21.52% | 0.00% |
| Feb. 6, 2024 | Cox Christopher Nixon | Not found | C | Common Stock | 588898 | $0.00 | 588,898.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Smith Nicholas Conrad | CHIEF FINANCIAL OFFICER | P | Common Stock | 1563 | $16.00 | 1,563.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | York Gwill | Not found | C | Series A Preferred Stock | 53196 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2024 | York Gwill | Not found | C | Common Stock | 23917 | $0.00 | 23,917.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Savitz Adam | CHIEF MEDICAL OFFICER | C | Series B Preferred Stock | 16666 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 1, 2024 | York Gwill | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | York Gwill | Not found | A | Stock Option (right to buy) | 3083 | $11.88 | 3,083.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Manji Husseini | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Manji Husseini | Not found | A | Stock Option (right to buy) | 3083 | $11.88 | 3,083.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Chen Po Yu (Jeff) | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Chen Po Yu (Jeff) | Not found | A | Stock Option (right to buy) | 1540 | $11.88 | 1,540.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Cox Christopher Nixon | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Cox Christopher Nixon | Not found | A | Stock Option (right to buy) | 4623 | $11.88 | 4,623.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Dreyfus Andrew | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |